Request Deal Involvement
Roivant Sciences went public via a SPAC merger with Montes Archimedes Acquisition in a $7.3bn deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
TD Cowen
financial advisors
Citigroup
financial advisors
JP Morgan
financial advisors
Leerink Partners
financial advisors
Goldman Sachs
financial advisors
Truist Securities
legal advisors
Davis Polk & Wardwell
pr advisors
Dukas Linden Public Relations
legal advisors
White & Case
financial advisors
Jefferies & Company
legal advisors
Kirkland & Ellis
pr advisors
Okapi Partners
legal advisors
Cooley
or
Principals
target
ROIVANT SCIENCES LTD
bidder
MONTES ARCHIMEDES ACQUISITION CORP
bidder
PATIENT SQUARE CAPITAL
bidder
FIDELITY MANAGEMENT & RESEARCH COMPANY
bidder
EVENTIDE ASSET MANAGEMENT
bidder
SUVRETTA CAPITAL
bidder
RTW INVESTMENTS
bidder
VIKING GLOBAL INVESTORS
bidder
SOFTBANK GROUP CORP
bidder
SUMITOMO DAINIPPON PHARMA
bidder
PALANTIR TECHNOLOGIES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite